Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
WD

Welcure Drugs & Pharmaceuticals Ltd

524661·Pharmaceuticals

Welcure Drugs And Pharmaceuticals Ltd used to manufacture pharmaceuticals productsBusiness Overview: Company manufactures and markets pharmaceuticals formulations in the form of tablets, capsules, dry syrups, antibiotics, sulpha drugs, vitamins, analgesics, antipyretics, corticosteroids, anti-malarial, anti-dysentery, anti-tuberculosis, anti-diabetics, tranquilizers, sedatives and gastrointestinal.

77Announcements
14-07-2026Last filed
3Last 90 days
welcuredrugs.com

What Welcure files

  • Updates26
  • Board Meeting20
  • Important17
  • Others10
  • Results2
  • Dividend/Bonus1
Showing Updates announcements (26)Clear filter
12-08-2025 · 11:10 am

WELCURE has announced a clarification regarding its upcoming board meeting on August 22, 2025. The company previously intimated proposals for a stock split and bonus issue, but inadvertently omitted the phrase 'up to'. The correct proposals for consideration are a stock split of equity shares up to 1:10, and an...

Read the full announcement→
PDF
11-08-2025 · 01:52 pm

Welcure Drugs & Pharmaceuticals Limited has announced a board meeting on 22 August 2025, to consider a stock split of equity shares in the ratio of 1:10, and an issue of bonus shares up to 1:1. These proposed corporate actions aim to broaden investor participation and enhance liquidity by reducing...

Read the full announcement→
PDF
08-08-2025 · 11:33 am

The company has announced a board meeting on Monday, November 13, 2023. The agenda includes approving the financial results for the quarter and half-year. The Board will also consider a fundraising proposal, potentially through a Preferential Issue of Warrants convertible into Equity Shares. Other methods like a Rights Issue, Qualified...

Read the full announcement→
PDF
05-08-2025 · 05:07 pm

Welcure Drugs & Pharmaceuticals announced the resignation of Mrs. Deepika Krishnan Iyer as a Non-Executive Independent Director, effective August 6. This marks a notable change in the company's board composition. Independent directors are vital for robust corporate governance and providing an objective perspective on company affairs. The Board acknowledged her...

Read the full announcement→
PDF
05-08-2025 · 05:02 pm

Welcure Drugs & Pharmaceuticals Ltd. announced that Mr. Suraj Chagan Solanki has resigned from his position as Non-Executive Non-Independent Director, effective August 6, 2025. His decision is due to pre-occupation, limiting his time commitment to the company's affairs. The Board of Directors has acknowledged his resignation and placed on record...

Read the full announcement→
PDF